Since its founding in 1994, Triple Point Biologics has been a pioneering provider of high-quality reagents for the study of matrix metalloproteinases (MMPs) and their endogenous inhibitors (TIMPs). Dedicated to advancing research, the company produces antibodies and purified proteins that help uncover the intricate roles of protease and protease inhibitors in both normal and pathological conditions. We strive to be the best and most inclusive resource for proteinase research. As the family of proteolytic enzymes and inhibitors expands, the Triple Point Biologics portfolio grows to meet the needs of the research community. All of our products are provided in a kit format, to provide the maximum in support.